LICENSE AGREEMENTLicense Agreement • April 25th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • England and Wales
BIAL – PORTELA & CA, S.A., a Portuguese corporation having a principal place of business at À Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Romão e S. Mamede), Portugal (hereinafter referred to as “BIAL”)
COMMERCIAL PACKAGING AGREEMENTCommercial Packaging Agreement • April 25th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
This Commercial Packaging Agreement (“Agreement”) is made as of this 12th day of December, 2016 (“Effective Date”), by and among Neurocrine Biosciences Inc., a corporation organized under the laws of Delaware, with offices at 12780 El Camino Real, San Diego, California, 92130, USA (“Client”) and AndersonBrecon Inc., an Illinois corporation, doing business as PCI of Illinois , with a place of business at 4545 Assembly Drive, Rockford, IL 61109 ( “PCI”).
PRODUCT AGREEMENT (INGREZZATM (valbenazine))Product Agreement • April 25th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • California
This Product Agreement (this “Product Agreement”) is issued under the Master Manufacturing Services Agreement dated 28 November 2016 between Patheon UK Limited and Neurocrine Biosciences Inc. (the “Master Agreement”), and is entered into 28 November 2016 (the “Effective Date”), between Patheon UK Limited, a corporation existing under the laws of England, having a principal place of business at Kingfisher Drive, Covingham, Swindon, SN3 5BZ, England (“Patheon”) and Neurocrine Biosciences Inc, 12780 El Camino Real, San Diego 92130, California, USA (“Client”).
Master Manufacturing Services Agreement 28 November 2016Product Agreement • April 25th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • England
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
